Quantcast

Latest Hemodialysis Stories

2014-07-30 16:29:56

ATLANTA, July 30, 2014 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that its Board of Directors has approved a quarterly cash dividend for the third quarter 2014 of $0.03 per share of common stock outstanding. The quarterly cash dividend of $0.03 per share will be paid on September 19, 2014 to all common stockholders of record as of September 12, 2014. The ex-dividend date...

2014-07-30 08:32:14

SAN ANTONIO, July 30, 2014 /PRNewswire/ -- Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access, today announced it has closed $4.5 million in Series A financing, which was led by Targeted Technology Fund II. Proceeds from the deal will allow Bluegrass Vascular to obtain CE Mark for the Surfacer(TM) Inside-Out Access Catheter System, enhance manufacturing capabilities, and proceed with US...

2014-07-24 08:34:37

RnRMarketResearch.com adds "Market Research Report on Global and Chinese Hemodialysis Machine Industry, 2009-2019" to its store. DALLAS, July 24, 2014 /PRNewswire-iReach/ -- Delivery of the Report will take 2-3 working days once order is placed. Photo - http://photos.prnewswire.com/prnh/20140723/129707 This is a professional and in-depth market survey on Global and Chinese Hemodialysis Machine industry. The report firstly reviews the basic information of Hemodialysis Machine...

2014-07-23 23:07:09

ChinaMarketResearchReports.com adds Latest Report on “China Hemodialysis Equipment Import and Export Report, 2013-2016” to its store. Complete report is available at http://www.chinamarketresearchreports.com/114870.html. Dallas, TX (PRWEB) July 23, 2014 Hemodialysis equipment is the most widely used treatment apparatus in blood purification, primarily targeting patients with acute or chronic renal failure. The Chinese hemodialysis equipment market shows a high concentration, mainly...

2014-07-23 16:27:28

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Renal Dialysis Equipment: Technologies and Global Marketshttps://www.reportbuyer.com/product/2070056/Renal-Dialysis-Equipment-Technologies-and-Global-Markets.htmlREPORT HIGHLIGHTSThe global market for dialysis equipment and accessories was valued at $12.5 billion in 2012 and $13.4 billion in 2013. This market is expected to be valued at nearly $18.8 billion in 2018, rising at a five-year...

2014-07-17 16:26:20

Analysis Shows Study Met Primary and All Secondary Endpoints THOUSAND OAKS, Calif., July 17, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that a Phase 3 study evaluating AMG 416 (formerly known as velcalcetide) for the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD), receiving hemodialysis, met its primary and all secondary endpoints. The primary endpoint was the proportion of patients with > 30 percent reduction from...

2014-07-16 12:27:25

NxStage Patient Advocates to travel the East Coast to share the benefits of home hemodialysis LAWRENCE, Mass., July 16, 2014 /PRNewswire/ -- NxStage® Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products, announced today the launch of the NxStage Freedom Tour, a two week road trip in a recreational vehicle to promote and educate dialysis patients on the benefits of home hemodialysis with the NxStage System One(TM). Traveling in the NxStage Freedom...

2014-07-10 12:28:45

Interest in GCS-100, Velcalcetide, ST-10, GSK-1278863A and Rayaldee Ranges from Moderate to High, According to Findings from Decision Resources Group BURLINGTON, Mass., July 10, 2014 /PRNewswire/ -- Decision Resources Group finds that over half of surveyed nephrologists report awareness of the U.S. Food and Drug Administration's (FDA) approval of Vifor Fresenius Medical Care Renal Pharma's new phosphate binder Velphoro, which was approved by the FDA in November 2013 for the treatment of...

2014-07-09 08:27:28

World-class Nephrologist to Lead Home Dialysis Program DENVER, July 9, 2014 /PRNewswire-USNewswire/ -- DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced that the company has named Martin Schreiber, M.D., as its new vice president of clinical affairs for home modalities. http://photos.prnewswire.com/prnvar/20140303/LA75036LOGO-b DaVita's home hemodialysis (HHD) and peritoneal dialysis (PD)...

2014-07-03 12:25:51

NxStage Patients embrace the flexibility of home hemodialysis to reclaim their lifestyles and live freely LAWRENCE, Mass., July 3, 2014 /PRNewswire/ -- In honor of Independence Day, NxStage Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products, joins patients across the nation in celebrating the freedom and flexibility they have reclaimed with home hemodialysis (HHD) using the NxStage® System One(TM)....


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related